{"id":18943,"date":"2021-10-12T10:15:32","date_gmt":"2021-10-12T14:15:32","guid":{"rendered":"https:\/\/medicarereport.org\/?p=18943"},"modified":"2021-10-12T10:15:32","modified_gmt":"2021-10-12T14:15:32","slug":"merck-asks-fda-to-authorize-promising-anti-covid-pill","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=18943","title":{"rendered":"Merck asks FDA to authorize promising anti-COVID pill"},"content":{"rendered":"<p>NPR<\/p>\n<p>WASHINGTON \u2014 Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world&#8217;s arsenal against the pandemic.<\/p>\n<p>If cleared by the Food and Drug Administration \u2014 a decision that could come in a matter of weeks \u2014 it would be the first pill shown to treat COVID-19. All other FDA-backed treatments against the disease require an IV or injection.\u00a0 Continue reading the article <a href=\"https:\/\/www.npr.org\/2021\/10\/11\/1045005513\/merck-asks-fda-to-authorize-promising-anti-covid-pill\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-3902\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\" alt=\"\" width=\"152\" height=\"55\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png 152w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo-150x55.png 150w\" sizes=\"auto, (max-width: 152px) 100vw, 152px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>NPR WASHINGTON \u2014 Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,52,15],"tags":[],"class_list":["post-18943","post","type-post","status-publish","format-standard","hentry","category-fda","category-pandemic","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18943"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18943\/revisions"}],"predecessor-version":[{"id":18944,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18943\/revisions\/18944"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}